The Effects of Adding Art Therapy to Ongoing Antidepressant Treatment in Moderate-to-Severe Major Depressive Disorder: A Randomized Controlled Study.
Myungjoo LeeHan ChoiJiwon ShinHo-Suk SuhPublished in: International journal of environmental research and public health (2022)
This randomized controlled study aimed to investigate the effects of art psychotherapy on moderate-to-severe major depressive disorder (MDD). Forty-two MDD patients were recruited from a psychiatric outpatient clinic in Seoul, the Republic of Korea. Participants were allocated on a randomized, open-label basis to either an experimental group, wherein they were treated with art psychotherapy added to pharmacotherapy, or a control group, wherein they were treated with pharmacotherapy alone. Pre- and post-test measures of the Hamilton Depression Rating Scale, Beck Depression Inventory-II, and remission rates were measured. The results indicate that patients treated with art psychotherapy and ongoing pharmacotherapy showed slightly greater improvement when compared with pharmacotherapy alone in moderate-to-severe MDD. These results suggest that art psychotherapy could be an effective add-on strategy for the treatment of moderate-to-severe MDD. However, a rigorous test would facilitate a better understanding of art psychotherapy as an add-on strategy for MDD treatment.
Keyphrases
- major depressive disorder
- bipolar disorder
- open label
- hiv infected
- early onset
- antiretroviral therapy
- newly diagnosed
- high intensity
- primary care
- smoking cessation
- clinical trial
- depressive symptoms
- posttraumatic stress disorder
- randomized controlled trial
- stem cells
- squamous cell carcinoma
- mental health
- rheumatoid arthritis
- borderline personality disorder
- phase iii
- mesenchymal stem cells
- prognostic factors
- locally advanced
- patient reported outcomes
- rectal cancer
- disease activity
- patient reported